| Senti Bio to Participate in Upcoming Investor Conferences | 09/03 08:15 | globenewswire.com |
| Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights | 08/13 16:05 | globenewswire.com |
| Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202 | 08/05 08:05 | globenewswire.com |
| Senti Bio Announces Reverse Stock Split | 07/16 08:30 | globenewswire.com |
| Complete Solaria, Senti, and POET: 3 High Volume Penny Stocks | 07/02 07:17 | marketbeat.com |
| Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy | 07/01 08:05 | globenewswire.com |
| Why Is Senti Biosciences (SNTI) Stock Up 32% Today? | 06/25 08:03 | investorplace.com |
| Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia | 05/13 08:15 | globenewswire.com |
| Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights | 05/09 16:05 | globenewswire.com |
| Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML) | 04/30 08:05 | globenewswire.com |